Literature DB >> 11826814

[INR self-management after mechanical heart valve replacement: ESCAT (Early Self-Controlled Anticoagulation Trial)].

H Körtke1, K Minami, T Breymann, D Seifert, A Baraktaris, O Wagner, G Kleikamp, A el-Banayosy, N Mirow, R Körfer.   

Abstract

Severe thromboembolic and hemorrhagic complications following mechanical heart valve replacement essentially occur due to intense oral anticoagulation and fluctuating individual INR values around the target range. INR self-management can help to minimize these fluctuations. Beginning this therapeutic control immediately after mechanical heart valve replacement further reduces anticoagulant-induced complications. Included in the study were 1200 patients. The quality of oral anticoagulation also improved through INR self-management. Over an observation period of two years, nearly 80% of INR values recorded by the patients themselves were within the target therapeutic range of 2.5-4.5. This corresponds to a high significance of p < = 0.001 in favor of INR self-management. Only 64.9% of INR values monitored by family practitioners were within the desired range. The results differed slightly in quality between patient groups with different levels of training (comprehensive, secondary modern, grammar with or without university). Of patients trained in INR self-management following mechanical heart valve replacement, 91.7% maintained their competence in this technique throughout the entire follow-up period. Only 8.3% of those trained immediately after surgery were unable to continue with INR self-management.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11826814

Source DB:  PubMed          Journal:  Z Kardiol        ISSN: 0300-5860


  7 in total

Review 1.  Anticoagulation for mechanical heart valves in patients with and without atrial fibrillation.

Authors:  Usman Baber; Sarina van der Zee; Valentin Fuster
Journal:  Curr Cardiol Rep       Date:  2010-03       Impact factor: 2.931

2.  American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy.

Authors:  Daniel M Witt; Robby Nieuwlaat; Nathan P Clark; Jack Ansell; Anne Holbrook; Jane Skov; Nadine Shehab; Juliet Mock; Tarra Myers; Francesco Dentali; Mark A Crowther; Arnav Agarwal; Meha Bhatt; Rasha Khatib; John J Riva; Yuan Zhang; Gordon Guyatt
Journal:  Blood Adv       Date:  2018-11-27

Review 3.  Self-monitoring and self-management of oral anticoagulation.

Authors:  Carl J Heneghan; Josep M Garcia-Alamino; Elizabeth A Spencer; Alison M Ward; Rafael Perera; Clare Bankhead; Pablo Alonso-Coello; David Fitzmaurice; Kamal R Mahtani; Igho J Onakpoya
Journal:  Cochrane Database Syst Rev       Date:  2016-07-05

Review 4.  Self-management of oral anticoagulation.

Authors:  Andrea Siebenhofer; Klaus Jeitler; Karl Horvath; Wolfgang Habacher; Louise Schmidt; Thomas Semlitsch
Journal:  Dtsch Arztebl Int       Date:  2014-02-07       Impact factor: 5.594

5.  Safety and effectiveness of point-of-care monitoring devices in patients on oral anticoagulant therapy: a meta-analysis.

Authors:  Philip S Wells; Allan Brown; James Jaffey; Lynda McGahan; Man-Chiu Poon; Karen Cimon
Journal:  Open Med       Date:  2007-10-16

6.  Supervised patient self-testing of warfarin therapy using an online system.

Authors:  Luke Ryan Elliot Bereznicki; Shane Leigh Jackson; Gregory Mark Peterson
Journal:  J Med Internet Res       Date:  2013-07-12       Impact factor: 5.428

7.  Self-management of patients with heart valve replacement and its clinical outcomes: a systematic review.

Authors:  Shirdel Zandi; Behzad Imani; Gholamreza Safarpor; Salman Khazaei
Journal:  Kardiochir Torakochirurgia Pol       Date:  2021-05-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.